Metropolis Healthcare IPO opened gate for Investors
On Wednesday, Metropolis Healthcare (MHL), one of the leading healthcare service providers in India opened subscriptions in an Initial Public Offering (IPO) of Rs. 1.24 Cr. The healthcare giant aims to sell 13,685,095 shares of these 6,272,335 shares will be sold by Dr. Sushil Shah, the promoter. For this IPO, the price ranges from Rs. 877-880 per share. The date of subscriptions will remain open till April 5.
MHL develops toolkits for diagnostic purposes in the healthcare domain. These toolkits are affordable yet considered to be best among other rivals in the market such as Dr. Lal Path Labs or Religare. Providing the fact that people invest and trust the brand, it is advisable to invest in MHL for long term goals. In a report, IDBI said- “Its strong brand equity and ability to offer comprehensive and critical diagnostic tests results with better realization per tests".
Metropolis has grown well in financial front as well as in medical services, in the past few years. However, HDFC securities also shared their concern regarding the market performance which is likely to get affected by legal proceedings. Also, the inability to effectively manage and implement business strategy can also prove to be a weak point in the market performance.
We suggest you to perform enough research before making your final call.